• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫内节育器:更新。

Intrauterine devices: an update.

机构信息

University of Arizona, Tucson, AZ, USA.

出版信息

Am Fam Physician. 2014 Mar 15;89(6):445-50.

PMID:24695563
Abstract

Three intrauterine devices (IUDs) are available in the United States: the copper T 380A and two levonorgestrel-releasing IUDs, one that releases 20 mcg of levonorgestrel per 24 hours, and one that releases 14 mcg per 24 hours. All are safe and effective methods of contraception that work predominantly by prefertilization mechanisms. The copper T 380A IUD may be placed in nonpregnant women at any time in the menstrual cycle. The prescribing information for the 20- and 14-mcg levonorgestrel-releasing IUDs advises that insertion occur during the first seven days of menses. Insertion immediately after vaginal or cesarean delivery may be considered with the copper T 380A and the 20-mcg levonorgestrel-releasing IUDs; however, expulsion rates are higher than with delayed postpartum insertion. The prescribing information for both levonorgestrel-releasing IUDs advises a waiting period of six weeks postpartum or following second-trimester pregnancy loss. Current guidelines indicate that IUDs are acceptable for use in nulliparous women, in adolescents, and in women who are breastfeeding. They may also be used in women who have a history of sexually transmitted infection, although screening is recommended. IUDs should not be inserted for at least three months after resolution of a sexually transmitted infection. Neither antibiotic prophylaxis nor misoprostol use before IUD insertion is beneficial. If pregnancy occurs, the IUD should be removed if feasible. Possible side effects of levonorgestrel-releasing IUDs include headaches, nausea, hair loss, breast tenderness, depression, decreased libido, ovarian cysts, oligomenorrhea, and amenorrhea. The main side effect of the copper T 380A IUD is increased menstrual bleeding, which may continue even with long-term use.

摘要

美国有三种宫内节育器(IUD):铜 T 380A 和两种左炔诺孕酮释放 IUD,一种每 24 小时释放 20 微克左炔诺孕酮,另一种每 24 小时释放 14 微克。所有这些都是安全有效的避孕方法,主要通过受精前机制发挥作用。铜 T 380A IUD 可在月经周期的任何时间放置于未怀孕的女性体内。20 微克和 14 微克左炔诺孕酮释放 IUD 的说明书建议在月经来潮的头七天内放置。在阴道分娩或剖宫产分娩后立即放置也可考虑使用铜 T 380A 和 20 微克左炔诺孕酮释放 IUD;然而,与产后延迟放置相比,其脱落率更高。两种左炔诺孕酮释放 IUD 的说明书均建议在产后六周或中期妊娠流产后六周等待期后再放置。当前的指南表明,IUD 可用于未生育的女性、青少年和哺乳期女性。对于有性传播感染史的女性,也可以使用 IUD,但建议进行筛查。在性传播感染治愈后,至少应等待三个月再放置 IUD。在放置 IUD 之前使用抗生素预防或米索前列醇均无益处。如果发生妊娠,应尽可能取出 IUD。左炔诺孕酮释放 IUD 的可能副作用包括头痛、恶心、脱发、乳房触痛、抑郁、性欲降低、卵巢囊肿、月经稀少和闭经。铜 T 380A IUD 的主要副作用是经量增加,即使长期使用也可能持续。

相似文献

1
Intrauterine devices: an update.宫内节育器:更新。
Am Fam Physician. 2014 Mar 15;89(6):445-50.
2
Intrauterine devices: an effective alternative to oral hormonal contraception.宫内节育器:口服激素避孕的有效替代方法。
Prescrire Int. 2009 Jun;18(101):125-30.
3
Intrauterine devices. The optimal long-term contraceptive method?宫内节育器。最佳的长期避孕方法?
J Reprod Med. 1999 Mar;44(3):269-74.
4
Modern intra-uterine devices.现代宫内节育器
Baillieres Clin Obstet Gynaecol. 1996 Apr;10(1):55-67. doi: 10.1016/s0950-3552(96)80062-9.
5
New developments in intrauterine devices.宫内节育器的新进展
Netw Res Triangle Park N C. 1991 Sep;12(2):9.
6
Reconsidering IUDs.重新审视宫内节育器
AVSC News. 1992 Jul;30(2):7-8.
7
Acceptability of IUDs is increasing.宫内节育器的可接受性正在提高。
Netw Res Triangle Park N C. 1992 Oct;13(2):27-30.
8
Intrauterine devices.宫内节育器
Contemp Rev Obstet Gynaecol. 1992 Oct;4(4):215-22.
9
Intrauterine contraception.宫内避孕
Curr Opin Obstet Gynecol. 1992 Aug;4(4):527-30.
10
Effectiveness of IUDs: a review.宫内节育器的有效性:一项综述。
Contraception. 1987 Jul;36(1):55-84. doi: 10.1016/0010-7824(87)90061-8.

引用本文的文献

1
Retention of a Copper T380A Intrauterine Device for 29 Years in a 64-Year-Old Female With Postmenopausal Bleeding.一名64岁绝经后出血女性体内的铜T380A宫内节育器留存29年
Cureus. 2025 Apr 17;17(4):e82444. doi: 10.7759/cureus.82444. eCollection 2025 Apr.
2
Immediate and delayed placement of the intrauterine device after abortion: a systematic review and meta-analysis.流产后即时和延迟放置宫内节育器:系统评价和荟萃分析。
Sci Rep. 2024 May 18;14(1):11385. doi: 10.1038/s41598-024-62327-1.
3
Role of Female Sex Hormones in ADPKD Progression and a Personalized Approach to Contraception and Hormonal Therapy.
女性性激素在常染色体显性多囊肾病进展中的作用以及避孕和激素治疗的个性化方法。
J Clin Med. 2024 Feb 22;13(5):1257. doi: 10.3390/jcm13051257.
4
A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Radiol Case Rep. 2021 Oct 2;16(12):3672-3674. doi: 10.1016/j.radcr.2021.08.074. eCollection 2021 Dec.
5
Uterine synechiae after intrauterine device use: a case series.宫内节育器使用后宫腔粘连:病例系列。
J Assist Reprod Genet. 2021 Oct;38(10):2625-2629. doi: 10.1007/s10815-021-02173-6. Epub 2021 Apr 8.
6
Swiss gynecologists' opinions and perceptions concerning the use of intrauterine devices by nulliparous and multiparous women: an online survey study.瑞士妇科医生关于未生育女性和经产妇使用宫内节育器的意见和看法:一项在线调查研究
Int J Womens Health. 2019 Mar 6;11:153-159. doi: 10.2147/IJWH.S189051. eCollection 2019.
7
Acute urticaria: an extremely rare adverse effect of levonorgestrel-releasing intrauterine system as a possible manifestation of progestogen hypersensitivity syndrome.急性荨麻疹:左炔诺孕酮宫内节育系统极其罕见的不良反应,可能是孕激素过敏综合征的一种表现。
Postepy Dermatol Alergol. 2018 Oct;35(5):530-531. doi: 10.5114/ada.2018.75748. Epub 2018 Jul 19.
8
Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004-2015.避孕药作为产后抑郁症的潜在风险因素:对2004年至2015年美国食品药品监督管理局不良事件报告系统的一项回顾性研究
Nurs Open. 2018 Jan 17;5(2):131-138. doi: 10.1002/nop2.121. eCollection 2018 Apr.
9
Animal models of contraception: utility and limitations.避孕的动物模型:效用与局限性。
Open Access J Contracept. 2015 Apr 17;6:27-35. doi: 10.2147/OAJC.S58754. eCollection 2015.